Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan
· Delayed Price · Currency is TWD 290.00
+1.00 (0.35%)
Feb 21, 2025, 1:30 PM CST
Sunmax Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 15,794 | 11,110 | 7,407 | 4,499 | 4,384 | 4,368 | Upgrade
|
| Market Cap Growth | 35.13% | 50.00% | 64.65% | 2.61% | 0.37% | 69.20% | Upgrade
|
| Enterprise Value | 15,296 | 10,469 | 6,785 | 3,756 | 3,685 | 3,853 | Upgrade
|
| Last Close Price | 290.00 | 196.71 | 125.89 | 73.80 | 70.19 | 68.44 | Upgrade
|
| PE Ratio | 22.62 | 17.76 | 13.88 | 18.31 | 18.42 | 43.48 | Upgrade
|
| PS Ratio | 9.06 | 6.58 | 5.29 | 4.34 | 5.12 | 7.35 | Upgrade
|
| PB Ratio | 11.55 | 7.79 | 5.59 | 4.40 | 4.93 | 6.45 | Upgrade
|
| P/TBV Ratio | 10.53 | 7.82 | 5.61 | 4.41 | 4.96 | 6.54 | Upgrade
|
| P/FCF Ratio | 33.16 | 15.00 | 15.12 | - | 17.05 | 15.84 | Upgrade
|
| P/OCF Ratio | 26.08 | 13.09 | 11.49 | 18.49 | 11.33 | 15.09 | Upgrade
|
| EV/Sales Ratio | 8.77 | 6.20 | 4.85 | 3.63 | 4.31 | 6.48 | Upgrade
|
| EV/EBITDA Ratio | 15.17 | 11.18 | 8.47 | 9.45 | 10.66 | 21.07 | Upgrade
|
| EV/EBIT Ratio | 16.74 | 11.70 | 8.83 | 10.22 | 11.09 | 22.01 | Upgrade
|
| EV/FCF Ratio | 32.11 | 14.13 | 13.85 | - | 14.33 | 13.97 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.12 | 0.05 | 0.10 | 0.15 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.17 | 0.08 | 0.23 | 0.35 | 0.62 | Upgrade
|
| Debt / FCF Ratio | 0.32 | 0.23 | 0.13 | - | 0.51 | 0.42 | Upgrade
|
| Asset Turnover | 0.91 | 0.85 | 0.85 | 0.73 | 0.69 | 0.64 | Upgrade
|
| Inventory Turnover | 2.79 | 3.39 | 3.23 | 3.53 | 4.65 | 2.37 | Upgrade
|
| Quick Ratio | 2.66 | 2.12 | 2.52 | 2.06 | 3.12 | 2.78 | Upgrade
|
| Current Ratio | 3.40 | 2.36 | 2.78 | 2.36 | 3.28 | 3.00 | Upgrade
|
| Return on Equity (ROE) | 53.12% | 45.48% | 45.45% | 25.69% | 30.41% | 15.16% | Upgrade
|
| Return on Assets (ROA) | 29.90% | 28.30% | 29.29% | 16.12% | 16.77% | 11.70% | Upgrade
|
| Return on Capital (ROIC) | 38.71% | 37.49% | 38.23% | 21.44% | 22.92% | 14.93% | Upgrade
|
| Return on Capital Employed (ROCE) | 56.50% | 52.59% | 52.34% | 31.94% | 31.07% | 20.91% | Upgrade
|
| Earnings Yield | 4.43% | 5.63% | 7.21% | 5.46% | 5.43% | 2.30% | Upgrade
|
| FCF Yield | 3.02% | 6.67% | 6.62% | -0.22% | 5.86% | 6.31% | Upgrade
|
| Dividend Yield | 3.79% | 5.59% | 7.55% | 5.96% | 2.85% | 2.19% | Upgrade
|
| Payout Ratio | 85.71% | 82.69% | 44.89% | 44.34% | 34.31% | 65.07% | Upgrade
|
| Buyback Yield / Dilution | 0.06% | 0.01% | -0.03% | 0.02% | 0.00% | -0.45% | Upgrade
|
| Total Shareholder Return | 3.86% | 5.60% | 7.52% | 5.98% | 2.85% | 1.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.